Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001829126-25-004015
Filing Date
2025-05-28
Accepted
2025-05-28 18:55:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 14230
2 EXHIBIT 99.2 calcimedica_ex99-2.htm EX-99.2 23885
  Complete submission text file 0001829126-25-004015.txt   40108
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91725 | Film No.: 25997127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11 WEST 42ND STREET, 9TH FLOOR NEW YORK NY 10036
Business Address 11 WEST 42ND STREET, 9TH FLOOR NEW YORK NY 10036 212-878-3523
Avenue Venture Opportunities Fund II, L.P. (Filed by) CIK: 0001886343 (see all company filings)

EIN.: 872781311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G